Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Nadler · SciRah

Researcher profile · Semantic Scholar

M. Nadler

Share profile

M. Nadler — researcher profile on SciRah

h-index: 13
Works: 72
Citations: 836

Most-cited papers

Oncology care provider perspectives on exercise promotion in people with cancer: an examination of knowledge, practices, barriers, and facilitators
M. Nadler, D. Bainbridge, J. Tomasone, Oren Cheifetz +2 more
2017Supportive Care in Cancer183 citations
Semantic Scholar
Effect of an interdisciplinary rehabilitation program on quality of life in patients with head and neck cancer: Review of clinical experience
M. Eades, Jessica Murphy, S. Carney, S. Amdouni +5 more
2013Head and Neck90 citations
Semantic Scholar
Comparison of treatment-related adverse events of different Cyclin-dependent kinase 4/6 inhibitors in metastatic breast cancer: A network meta-analysis.
A. Desnoyers, M. Nadler, Vikaash Kumar, R. Saleh +1 more
2020Cancer Treatment Reviews67 citations
Semantic Scholar
The effect of exercise on quality of life, fatigue, physical function and safety in advanced solid tumor cancers: a meta-analysis of randomized control trials.
M. Nadler, A. Desnoyers, David M. Langelier, E. Amir
2019Journal of Pain and Symptom Management64 citations Open access
Semantic Scholar
Influence of Competing Risks on Estimates of Recurrence Risk and Breast Cancer-specific Mortality in Analyses of the Early Breast Cancer Trialists Collaborative Group
R. Saleh, M. Nadler, A. Desnoyers, D. Rodin +2 more
2019Scientific Reports49 citations Open access
Semantic Scholar
Longitudinal evaluation of circulating tumor DNA in patients undergoing neoadjuvant therapy for early breast cancer using a tumor-informed assay
M. Elliott, Philippe Echelard, C. Pipinikas, S. Main +15 more
2025Nature Communications44 citations Open access
Semantic Scholar
Comparative overall survival of CDK4/6 inhibitors in combination with endocrine therapy in advanced breast cancer
C. Kappel, M. Elliott, Vikaash Kumar, M. Nadler +2 more
2024Scientific Reports42 citations Open access
Semantic Scholar
Osteoporosis knowledge, health beliefs, and healthy bone behaviours in patients on androgen‐deprivation therapy (ADT) for prostate cancer
M. Nadler, S. Alibhai, P. Catton, C. Catton +2 more
2013BJU International40 citations
Semantic Scholar
Platinum-based chemotherapy in early-stage triple negative breast cancer: A meta-analysis.
R. Saleh, M. Nadler, A. Desnoyers, Nicholas Meti +2 more
2021Cancer Treatment Reviews25 citations
Semantic Scholar
MRI surveillance for women with dense breasts and a previous breast cancer and/or high risk lesion.
M. Nadler, H. Al-Attar, E. Warner, Anne L. Martel +4 more
2017Breast23 citations Open access
Semantic Scholar
Fragility index of trials supporting approval of anti-cancer drugs in common solid tumours.
A. Desnoyers, B. E. Wilson, M. Nadler, E. Amir
2021Cancer Treatment Reviews17 citations
Semantic Scholar
The Exercise Oncology Knowledge Mobilization Initiative: An International Modified Delphi Study
S. C. Adams, J. Smith-Turchyn, Daniel Santa Mina, S. Neil-Sztramko +9 more
2021Frontiers in Oncology17 citations Open access
Semantic Scholar
Network Meta-analysis Comparing Efficacy, Safety and Tolerability of Anti-PD-1/PD-L1 Antibodies in Solid Cancers
L. Al-Showbaki, M. Nadler, A. Desnoyers, F. Almugbel +2 more
2021Journal of Cancer14 citations Open access
Semantic Scholar
Moving Cancer Care Ontario’s Exercise for People with Cancer guidelines into oncology practice: using the Theoretical Domains Framework to validate a questionnaire
M. Nadler, D. Bainbridge, A. Fong, J. Sussman +2 more
2019Supportive Care in Cancer14 citations
Semantic Scholar
Coronary artery disease in patients with cancer: challenges and opportunities for improvement
Montserrat Carrillo-Estrada, D. Bobrowski, R. Carrasco, M. Nadler +3 more
2021Current Opinion in Cardiology13 citations
Semantic Scholar
The impact of bone mineral density testing, fracture assessment, and osteoporosis education in men treated by androgen deprivation for prostate cancer: a pilot study
M. Nadler, S. Alibhai, P. Catton, C. Catton +1 more
2014Supportive Care in Cancer12 citations
Semantic Scholar
State of research, feasibility, safety, acceptability, and outcomes examined on remotely delivered exercises using technology for older adult with cancer: a scoping review
S. Sattar, E. Papadopoulos, G. Smith, K. Haase +7 more
2023Journal of cancer survivorship10 citations
Semantic Scholar
Rationale and design of IMPACT-women: a randomised controlled trial of the effect of time-restricted eating, healthy eating and reduced sedentary behaviour on metabolic health during chemotherapy for early-stage breast cancer
R. Christensen, M. Haykowsky, M. Nadler, C. Prado +7 more
2022British Journal of Nutrition10 citations Open access
Semantic Scholar
Associations with response to Poly(ADP-ribose) Polymerase (PARP) inhibitors in patients with metastatic breast cancer
A. Desnoyers, M. Nadler, B. E. Wilson, S. Stajer +1 more
2022npj Breast Cancer10 citations Open access
Semantic Scholar
Quantifying Withdrawal of Consent, Loss to Follow-Up, Early Drug Discontinuation, and Censoring in Oncology Trials.
B. E. Wilson, M. Nadler, A. Desnoyers, E. Amir
2021The Journal of the National Comprehensive Cancer Network8 citations Open access
Semantic Scholar
Strategies to support health care providers during the COVID-19 pandemic
M. Nadler, A. Barry, Tracy Murphy, R. Prince +1 more
2020Canadian Medical Association Journal8 citations Open access
Semantic Scholar
Differential treatment effect between younger and older adults for new cancer therapies in solid tumors supporting US Food and Drug Administration approval between 2010 and 2021
B. E. Wilson, A. Desnoyers, M. Nadler, E. Amir +1 more
2023Cancer7 citations Open access
Semantic Scholar
A critique of the fragility index.
A. Desnoyers, M. Nadler, B. E. Wilson, E. Amir
2019The Lancet Oncology7 citations
Semantic Scholar
Magnitude of effect and sample size justification in trials supporting anti-cancer drug approval by the US Food and Drug Administration
M. Nadler, Brooke E. Wilson, A. Desnoyers, C. M. Valiente +2 more
2024Scientific Reports6 citations Open access
Semantic Scholar
Meta‐analysis of sex and racial subgroup participation rates and differential treatment effects for trials in solid tumor malignancies leading to US Food and Drug Administration registration between 2010 and 2021
B. E. Wilson, M. Nadler, A. Desnoyers, Christopher M. Booth +1 more
2023Cancer6 citations Open access
Semantic Scholar
Development of an evidence-informed recommendation guide to facilitate physical activity counseling between oncology care providers and patients in Canada.
A. Fong, C. Sabiston, M. Nadler, J. Sussman +4 more
2021Translational Behavioral Medicine6 citations Open access
Semantic Scholar
Fragility of randomized trials supporting cancer drug approvals stratified by approval pathway and review designations
B. E. Wilson, A. Desnoyers, M. Nadler, A. Tibau +1 more
2021Cancer Medicine6 citations Open access
Semantic Scholar
Increasing Referrals of Patients With Gastrointestinal Cancer to a Cancer Rehabilitation Program: A Quality Improvement Initiative.
M. Nadler, A. Rose, R. Prince, L. Eng +4 more
2020JCO Oncology Practice6 citations
Semantic Scholar
Steatotic liver disease in metastatic breast cancer treated with endocrine therapy and CDK4/6 inhibitor
D. Malón, C. Molto, S. Prasla, Danielle Cuthbert +9 more
2024Breast Cancer Research and Treatment5 citations Open access
Semantic Scholar
A retrospective analysis of changes in distant and breast cancer related disease-free survival events in adjuvant breast cancer trials over time
B. E. Wilson, A. Desnoyers, L. Al-Showbaki, M. Nadler +1 more
2022Scientific Reports4 citations Open access
Semantic Scholar
Patient and provider determinants of breast cancer screening among Ontario women aged 40–49: a population-based retrospective cohort study
M. Nadler, N. Ivers, A. Marchand-Austin, A. Lofters +4 more
2021Breast Cancer Research and Treatment4 citations
Semantic Scholar
Abstract PS06-08: Longitudinal Neoadjuvant and Post-operative Evaluation of Circulating Tumor DNA in Early Breast Cancer using a Tumor-Informed Assay: Updated Analysis of the TRACER Cohort
M. Elliott, J. F. Antrás, Philippe Echelard, A. Dou +14 more
2024Cancer Research3 citations
Semantic Scholar
Perceived guideline clarity impacts guideline-concordant care for breast cancer screening in women age 40–49
M. Nadler, A. M. Corrado, B. E. Wilson, A. Desnoyers +3 more
2023BMC Women's Health3 citations Open access
Semantic Scholar
Abstract P4-07-02: Toxicity profile of single agent trastuzumab deruxtecan in solid tumors: A meta-analysis
F. Tamimi, A. Mittal, C. M. Valiente, Massimo Di Iorio +3 more
2023Cancer Research3 citations
Semantic Scholar
Determinants of guideline-concordant breast cancer screening by family physicians for women aged 40–49 years: a qualitative analysis
M. Nadler, A. M. Corrado, Laura Desveaux, S. Neil-Sztramko +4 more
2022CMAJ Open3 citations Open access
Semantic Scholar
Towards a Postgraduate Oncology Training Model for Family Medicine: Mixed Methods Evaluation of a Breast Oncology Rotation
M. Nadler, Brooke E. Hofbauer, Melinda Wu, S. Hum +2 more
2022Current Oncology3 citations Open access
Semantic Scholar
Comparative overall survival of patients in trials of CKD4/6 inhibitors in combination with endocrine therapy in advanced breast cancer.
C. Kappel, M. Elliott, Vikaash Kumar, M. Nadler +2 more
2023Journal of Clinical Oncology2 citations Open access
Semantic Scholar
Comparative efficacy, safety, and tolerability of immune checkpoint inhibitors (ICIs) in cancer.
L. Al-Showbaki, M. Nadler, A. Desnoyers, F. Almugbel +2 more
2020Journal of Clinical Oncology2 citations
Semantic Scholar
Abstract P6-01-16: Circulating Tumour DNA (ctDNA) Detection and Dynamics in Patients with Early Breast Cancer (EBC): Results of the Neoadjuvant TRACER cohort
M. Elliott, Z. Veitch, Philippe Bédard, E. Amir +14 more
2023Cancer Research1 citations
Semantic Scholar
Metformin to Prevent Anthracycline Cardiotoxicity?
Malak El-Rayes, M. Nadler, H. Abdel-Qadir
2023JACC CardioOncology1 citations Open access
Semantic Scholar
Abstract P4-15-01: Fragility index of trials supporting approval of breast cancer drugs
A. Desnoyers, M. Nadler, R. Saleh, E. Amir
20201 citations
Semantic Scholar
The efficacy and safety of exercise in metastatic solid cancer: A meta-analysis of randomized control trials.
M. Nadler, R. Saleh, A. Desnoyers, E. Amir
2019Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Oncologists’ knowledge, clinical practices, barriers and facilitators of cardio-oncology guideline-concordant care.
K. Ronan, C. Kappel, Eitan Amir, J. Savill +8 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Cost-effectiveness of post-discharge home care for reducing potentially avoidable readmissions in stage IV cancer.
Amal Aljuhani, Vanessa Huels, M. Nadler, E. Amir +5 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Oral selective estrogen receptor degraders in HR+/HER2- advanced breast cancer and impact of ESR1 mutation status: A systematic review and meta-analysis.
Amal Aljuhani, Maymoona Altarturi, M. Nadler, U. Bender +4 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
The role of stereotactic body radiotherapy in oligoprogressive breast cancer: A site-specific analysis of the prospective, phase-II RADIANT trial
K. Ruicci, J. Helou, A. Barry, Xiang Y. Ye +17 more
2026Clinical and Translational Radiation Oncology0 citations Open access
Semantic Scholar
Differential Treatment Effects by Smoking Status for NSCLC Therapies (2010–2023): A Meta-Analysis
F. Favorito, Fabio Ynoe de Moraes, C. M. Valiente, M. Nadler +3 more
2025JTO Clinical and Research Reports0 citations Open access
Semantic Scholar
Safety and Effectiveness of Adriamycin and Cyclophosphamide Followed by Dose Dense (Every 2 Weeks) Paclitaxel Given With Trastuzumab as Neoadjuvant Treatment in HER2-Positive Early-Stage Breast Cancer.
Y. Berner-Wygoda, Meredith Li, Chloe Perlon, D. Malón +6 more
2025Clinical Breast Cancer0 citations
Semantic Scholar
Characterization of molecular response and progression in patients with metastatic HR+/HER2- breast cancer receiving endocrine therapy and CDK4/6 inhibitors using a high-sensitivity tumor-informed assay.
J. F. Antrás, M. Elliott, S. Main, Philippe Echelard +16 more
2024Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Abstract 969: Tumor-agnostic ctDNA monitoring in patients with metastatic HR+/HER2- breast cancer receiving first-line CDK4/6 inhibitor and endocrine therapy
M. Elliott, J. Fuentes-Antrás, A. Dou, Nancy Gregorio +11 more
2024Cancer Research0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Amir×24
Invite
E. Amir — researcher profile on SciRah
A. Desnoyers×23
Invite
A. Desnoyers — researcher profile on SciRah
B. E. Wilson×11
Invite
B. E. Wilson — researcher profile on SciRah
E. Amir×10
Invite
E. Amir — researcher profile on SciRah

×7

Invite

M. Elliott — researcher profile on SciRah

Invite

R. Saleh — researcher profile on SciRah

Invite

D. Cescon — researcher profile on SciRah

Invite

A. Dou — researcher profile on SciRah

Elizabeth Shah×5

Invite

Elizabeth Shah — researcher profile on SciRah

Invite

L. Siu — researcher profile on SciRah

Hal K. Berman×5

Invite

Hal K. Berman — researcher profile on SciRah

Invite

J. Savill — researcher profile on SciRah